clinical essentials for assessment and treatment of cognitive-communication disorders Bayles, Kathryn A. 1942- creator Tomoeda, Cheryl K. text bibliography cau San Diego, CA Plural Publishing [2013] 2013 monographic eng

print

xix, 209 pages : illustrations ; 23 cm Introduction Definition and discussion of the dementia syndrome and its significance in terms of prevalence and cost. MCI Defined Explanation of MCI, its various forms, the recently revised diagnostic criteria established by the NIH and the Alzheimer's Association, information about rate of conversion to AD, and a review of early changes in language and cognition. Alzheimer's Dementia Defined Diagnostic criteria, neuropathology, risk factors, effects on cognition and communication by stage of disease, and samples of the language of affected individuals by stage of disease. Assessment of MCI and AD The process of assessment, reviews of commonly used tests and severity measures, recommendations on tests for screening and comprehensive assessment, and differential diagnosis. Rationale for intervention Evidence from cognitive science for the involvement of SLPs in identifying individuals with MCI and AD and treating them directly and indirectly through caregiver counseling to sustain, improve, and/or maximize functioning. Treatment of MCI Options SLPs have for helping clients sustain function, including cognitive wellness programs. Direct Treatment of AD Treatment guidelines and evidence-based techniques for facilitating learning and information retrieval. Indirect Treatment of AD Modifications that SLPs can recommend and oversee regarding the physical and linguistic environment that will enable affected individuals to function at their highest level of ability. Specific recommendations are included about how to communicate with affected individuals and how to improve their ability to comprehend and express language. Kathryn A. Bayles, author, Cheryl K. Tomoeda, author. Includes bibliographical references and index. Mild Cognitive Impairment diagnosis Aged Alzheimer Disease diagnosis Alzheimer Disease therapy Mild Cognitive Impairment therapy RC523 .B39 2013 616.831 BAY T WT 150 9781597565189 (pbk. : alk. paper) 1597565180 (pbk. : alk. paper) 2013014051 DNLM/DLC 130405 20191003171010.0 17688233